Although interleukin-2 (IL-2) was initially characterized as the primary T-cell growth factor following in vitro activation 1 , less is known about its role in shaping T-cell responses to acute infections in vivo. The use of IL-2-or IL-2-receptor-deficient mice is problematic owing to their early development of autoimmunity 2-5 , attributable to the central role of IL-2 in the generation, maintenance and function of CD4
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1 regulatory T cells [6] [7] [8] [9] . To bypass these inherent difficulties, we have studied the effect of IL-2 on T-cell responses to acute infections by adopting a mixed chimaera strategy in which T cells lacking the high-affinity IL-2 receptor could be studied in an otherwise healthy mouse containing a full complement of regulatory T cells. Here we show that although IL-2 signalling to pathogen-specific CD8
1 T cells affects the number of developing effector and memory cells very little, it is required for the generation of robust secondary responses. This is not due to an altered T-cell-receptor repertoire development or selection, and does not reflect an acute requirement for IL-2 during secondary activation and expansion. Rather, we demonstrate a previously unappreciated role for IL-2 during primary infection in programming the development of CD8 1 memory T cells capable of full secondary expansion. These results have important implications for the development of vaccination or immunotherapeutic strategies aimed at boosting memory T-cell function.
In recent years, many factors required for the generation, homeostatic turnover, and long-term survival of memory T cells have been identified, including cytokines such as IL-7 and IL-15 (refs 10-13) . CD4 þ T cells, though largely dispensable for primary CD8 þ T cell responses to many acute infections, play a particularly crucial role in the generation of functional CD8 þ memory T cells [14] [15] [16] [17] [18] . IL-2, a product of CD4 þ T cells, is a member of the same cytokine family as IL-7 and IL-15 by virtue of its shared usage of the common g chain as part of its receptor and was an obvious candidate for further study. Early reports conflict on the ability of T cells to respond to infection in the setting of IL-2 deficiency 19, 20 , but these studies remain difficult to interpret, because IL-2-and IL-2R-deficient mice develop lymphoproliferation and autoimmunity at an early age [2] [3] [4] [5] . More recent attempts to study IL-2 in healthy hosts have found that it plays a surprisingly modest role in driving the development of effector cytotoxic T lymphocytes [21] [22] [23] . We aimed to study the long-term impact of IL-2 signalling on the development of CD8 þ memory T-cell numbers and function in mice that did not suffer from ongoing autoimmune disease. To create this setting, we made mixed bone-marrow chimaeras in which irradiated C57BL/6 (B6) mice (CD45.1 þ ) were reconstituted with T-cell-depleted bone marrow from B6 (Thy1.1 þ ) and IL-2Ra-deficient (Thy1.2 þ ) donors (hereafter referred to as WT/IL-2Ra 2/2 chimaeras), thus allowing us to track wild-type (WT) and IL-2Ra-deficient T-cell responses in a healthy mouse with a full complement of regulatory T cells (Supplementary Fig. 1) .
Following acute infection of WT/IL-2Ra 2/2 chimaeras with lymphocytic choriomeningitis virus (LCMV), both WT and IL-2Ra-deficient CD8 þ T cells generated comparable populations of effector and memory cells specific for the immunodominant epitope of the LCMV glycoprotein, GP [33] [34] [35] [36] [37] [38] [39] [40] [41] (Fig. 1a) . Similar results were seen for another immunodominant CD8 epitope, NP [396] [397] [398] [399] [400] [401] [402] [403] [404] , and for the immunodominant CD4 epitope GP 61-80 (data not shown). However, following a rechallenge with Listeria monocytogenes secreting the GP 33-41 epitope (LM-GP), IL-2Ra-deficient memory cells mounted highly impaired secondary responses (Fig. 1a) . Whereas the frequencies of WT to IL-2Ra-deficient memory cells were maintained at or near a ratio of 2:1, this ratio rose to 14:1 after re-challenge (Fig. 1b) . Furthermore, while WT memory cells expanded nearly 40-fold after re-challenge, IL-2Ra-deficient memory cells only expanded fourfold (Fig. 1c) . These results were repeated when LCMV-immune chimaeras were re-challenged with a high dose of LCMV ( Supplementary Fig. 2 ) and when chimaeras immune to a recombinant Listeria monocytogenes secreting ovalbumin (LM-Ova) were given a high-dose secondary challenge with LM-Ova (Supplementary Fig. 3 ).
To determine whether the inability of IL-2Ra-deficient memory cells to respond to re-challenge was due to altered T-cell repertoire development or selection in the absence of IL-2 signalling, we measured the responses of WT and IL-2Ra-deficient P14 T-cellreceptor transgenic cells (specific for the GP 33-41 epitope of LCMV) after LCMV infection. To ensure that these cells would develop in hosts with sufficient regulatory T cells, we generated mixed chimaeras using a mixture of B6 bone marrow and either WTor IL-2Ra-deficient P14 bone marrow to reconstitute lethally irradiated B6 mice. Eight weeks later, CD44 lo P14 T cells were harvested from these chimaeras and co-transferred into new B6 hosts, followed by LCMV infection ( Supplementary Fig. 4 ). Because the WT P14 donors were Thy1.2 þ , the IL-2Ra-deficient P14 donors were Thy1.1
, and the recipient host was Thy1.1 þ , we were able to measure the responses of WT and IL-2Ra-deficient P14 cells in the same host.
Following LCMV infection, both WT and IL-2Ra-deficient P14 T cells expanded robustly and developed long-term memory populations in the spleen (Fig. 2a, b ) and in the mesenteric lymph nodes and liver ( Supplementary Fig. 5 ). Furthermore, both WT and IL-2Ra-deficient P14 memory cells displayed normal homeostatic turnover, as assessed by 5-bromo-2 0 -deoxyuridine (BrdU) incorporation over a 7-day period (Fig. 2c ). Both groups of memory cells expressed similarly high levels of CD122 and CD44 (data not shown), while the frequency of cells expressing CD62L and IL-7Ra was actually higher at all memory time points in the IL-2Ra-deficient population than in the WT memory population (Fig. 2d) . Furthermore, following ex vivo re-stimulation IL-2Ra-deficient memory cells rapidly upregulated CD69 and contained a consistently higher frequency of IL-2-producers than WT memory cells ( Supplementary  Fig. 6 ). The phenotype of the IL-2Ra-deficient cells was consistent with a central memory-like phenotype, which has been shown to correlate with high proliferative and protective capacity 24 . The rapid loss of CD62L lo cells in the IL-2Ra-deficient population may reflect a previously suggested role for IL-2 in driving the differentiation of effector memory 25 . A recent study observed that the early accumulation of cells with a central memory phenotype depends on a high precursor frequency of antigen-specific cells 26 . We found that CD62L hi cells emerged more rapidly in the IL-2Ra-deficient population even when as few as 500 WT and IL-2Ra-deficient P14 cells were co-transferred so that precursor frequencies approached endogenous levels ( Supplementary Fig. 7) .
At memory time points, WT and IL-2Ra-deficient P14 cells were sorted and transferred into new B6 hosts in equal numbers. Following a secondary LCMV challenge, the WT memory cells far outpaced the IL-2Ra-deficient memory cells in their ability to expand (Fig. 3a) . Whereas WT P14 T cells had only a 2:1 advantage over the IL-2Ra-deficient P14 T cells at the peak of the primary effector response, at the peak of the secondary response this ratio approached 20:1 (Fig. 3b) . Similar results were again obtained when the precursor frequency of transferred P14 cells was similar to endogenous precursor frequencies ( Supplementary Fig. 7) , showing that IL-2 plays a central role for long-term protective immunity independently of T-cell repertoire development or selection. Following co-transfer of carboxyfluorescein diacetate succinimidyl ester (CFSE)-labelled WT and IL-2Ra-deficient memory P14 into new hosts and re-challenge with LCMV, both groups rapidly diluted their CFSE within three days. However, even within this short time of antigen re-exposure WT P14 cells accumulated to far greater numbers than IL-2Ra-deficient P14 cells (Fig. 3c) , indicating that IL-2 is not required to drive proliferation of memory cells following secondary antigen encounter but instead promotes the survival and accumulation of dividing cells.
We hypothesized that IL-2 signalling could play a role in promoting secondary T-cell expansion during three separate phases of the immune response: during the primary response, during memory maintenance, or following re-challenge. To address this question, we took advantage of the recent observation that the anti-IL-2 antibody S4B6, previously thought to be neutralizing, actually enhances the potency of IL-2 in vivo for T cells bearing the intermediate affinity receptor for IL-2, IL2Rbg (ref. 27 ). In that study, co-administration of small amounts of recombinant IL-2/anti-IL-2 immune complexes resulted in the delivery of a potent signal through IL2Rbg that was independent of IL-2Ra. To determine whether IL-2/anti-IL-2 immune complexes could deliver functional IL-2 signals during acute infection, we injected 1 £ 10 4 naive WT and IL-2Ra-deficient P14 cells into B6 mice as described previously ( Supplementary Fig. 3 ), infected them with LCMV and treated mice with IL-2/anti-IL-2 immune complexes or with anti-IL-2 alone. WT and IL-2Ra-deficient P14 cells expanded to similar levels by day 8 post-infection in all treatment groups (data not shown). As seen previously (Fig.  2d) , by day 19 post-infection, 35-40% of IL-2Ra-deficient cells expressed CD62L in untreated mice, compared to 10-13% of WT P14 cells. In contrast, IL-2Ra-deficient P14 cells in mice treated during the primary response with IL-2/anti-IL-2 immune complexes or with anti-IL-2 alone had levels of CD62L expression that were similar to WT P14 cells (Fig. 4a) , indicating that the signalling of IL-2/anti-IL-2 immune complexes through IL2Rbg can provide a functional IL-2 signal during acute infection.
Because the activity of the complexes is short-lived 27 , we were able to design experiments in which the timing of IL-2 signals to IL-2Ra-deficient T cells could be manipulated. WT/IL-2Ra 2/2 mixed chimaeras were infected with LCMV and either left untreated, injected with anti-IL-2 alone or injected with IL-2/anti-IL-2 complexes daily for the first six days of infection. Both WT and IL-2Ra-deficient CD8 T cells developed comparable effector and memory populations (data not shown). Six weeks after infection mice were re-challenged with a high dose of LM-GP, and further treatment groups received daily injections of IL-2/anti-IL-2 immune complexes or anti-IL-2 alone during the secondary response. Treatment with IL-2/anti-IL-2 immune complexes or with anti-IL-2 alone during the primary response rescued the ability of IL-2Ra-deficient CD8 memory cells to respond to re-challenge. Conversely, treatment with immune complexes during the secondary response only modestly improved the expansion of IL-2Ra-deficient CD8 memory cells, while treatment with anti-IL-2 alone had no effect (Fig. 4b,c) . We conclude that IL-2 signalling during the primary response programmed the formation of fully responsive CD8 memory cells capable of generating robust recall responses.
To determine whether IL-2 signals to CD8 þ T cells were autocrine, we generated mixed chimaeras with a mix of B6 and IL-2-deficient bone marrow. In this scenario, IL-2-deficient T cells are dependent on paracrine IL-2 signalling. We observed no differences in either the primary or secondary responses of WT and IL-2-deficient T cells, demonstrating that paracrine IL-2 signalling is sufficient for the development of fully functional CD8 þ memory cells ( Supplementary  Fig. 8 ). What cell type, then, is the source of IL-2 for promoting the development of functional CD8 þ memory T cells? One candidate is the CD4 subset, because activated CD4 þ T cells are the major source of IL-2 in vivo. Alternatively, IL-2 may come from other sources, including other activated CD8 þ T cells, as well as activated dendritic cells 28 . Signals delivered during the programming of immune responses can shape the long-term fate and function of CD8 memory cells 15, 16 , and we show here that IL-2 signalling during the primary response to acute infection affects the ability of the subsequently arising CD8 þ memory T cell population to survive and accumulate following secondary antigen exposure. Future studies should focus on the specific pathways by which IL-2 signalling during the primary response promotes enhanced survival of CD8 þ T cells during the recall response. More experiments are also required to delineate the role of IL-2 in a broad spectrum of in vivo immune responses, including those directed towards other types of acute and chronic infections, tumours, and protein and DNA immunizations. Resolving these questions will be an important step in understanding the mechanisms by which fully functional CD8 þ memory T cells are generated.
METHODS
Mice and infections. 6-8-week-old C57BL/6 (Thy1.2 þ ), B6.SJL-PtprcaPep3b/ BoyJ (CD45.1 þ ) and B6.PL-Thy1a/CyJ (Thy1.1 þ ) mice, and 4-week-old B6.129P2-Il2tm1Hor/J (IL-2-deficient) and B6.129S4-Il2ratm1Dw/J (IL-2Ra-deficient) mice were purchased from Jackson Laboratories. P14 T-cell-receptor transgenic mice were bred at our facilities. Mice were infected with LCMVArmstrong, LM-Ova or LM-GP (provided by H. Shen, Univ. Pennsylvania), as described 17, 18 . Viral and bacterial stocks were prepared and propagated as described 18, 29 . Mice were injected intraperitoneally daily with 50 mg anti-IL-2 (clone S4B6) alone or anti-IL-2 and 1.5 mg recombinant mouse IL-2 (eBiosciences) as described 27 . Generation of mixed bone marrow chimaeras. Bone marrow preparations from femur and tibia were incubated with anti-CD3-biotin antibody and antibiotin magnetic beads, followed by bead depletion on an AutoMacs (Miltenyi). 5 £ 10 6 T-cell-depleted bone marrow cells from each of the indicated donors were injected intravenously into lethally irradiated B6 hosts (1,000 rad). Mice were infected 8-12 weeks post-transplant. BrdU and CFSE labelling. Mice were fed 0.8 mg ml 21 BrdU (Sigma) in their drinking water for 7 days and stained for BrdU incorporation according to the manufacturer's instructions (BD Pharmingen). Splenocytes were labelled in 5 mM CFSE (Molecular Probes) for 7 min in warm RPMI. Cell preparations and ex vivo restimulations. For transfer of P14 cells, CD44 hi cells were depleted by incubation with anti-CD44-biotin, followed by magnetic bead depletion with anti-biotin beads (Miltenyi). Ex vivo restimulations were performed as described 30 and intracellular cytokine staining was carried out according to the manufacturer's instructions (Cytofix/Cytoperm kit, BD Pharmingen). Antibody staining and flow cytometry. Cells were stained with directly conjugated antibodies purchased from BD Pharmingen or eBiosciences and analysed on either a FACSCalibur or FACSCanto flow cytometer (Becton Dickinson). Two-way cell sorting was performed on a FACSAria (Becton Dickinson).
